RTX Corp: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Oct 25, 2019 and accepted by EDGAR at Oct 24, 2019, 21:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $19.50bn | us-gaap:Revenues |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $57.49bn | us-gaap:Revenues |
| Research and development | 3 months2019-07-01 to 2019-09-30 | $732.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-30 | $2.20bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-07-01 to 2019-09-30 | $2.10bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-01-01 to 2019-09-30 | $6.21bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-07-01 to 2019-09-30 | $2.49bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-30 | $7.12bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-07-01 to 2019-09-30 | $401.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-01-01 to 2019-09-30 | $1.19bn | us-gaap:InterestExpense |
| Income tax | 3 months2019-07-01 to 2019-09-30 | $1.13bn | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $1.97bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $1.15bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-30 | $4.39bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-30 | $1.33 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-30 | $5.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | $5.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-30 | 864,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-30 | 862,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | $6.10bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2019-01-01 to 2019-09-30 | $1.36bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2019-01-01 to 2019-09-30 | $1.83bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2019-01-01 to 2019-09-30 | $111.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-09-30 | $7.34bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $37.82bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $139.01bn | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $35.57bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-30 | $96.08bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2019-09-30 | $1.33bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-09-30 | $40.47bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-09-30 | 863,268,940 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-19-000047. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.